Oncology Precision Medicine Market Share, Global Industry Size, Trends, Technology, and Analysis by 2035
This report presents a detailed, data-driven analysis of the global Oncology Precision Medicine Market size, offering insights into historical performance, current dynamics, and projections from 2025 to 2035. With a strong emphasis on factual assessment, the report refrains from speculative assumptions and aims to support business decisions through accurate forecasting and strategic intelligence.
I recently came across a report by Roots Analysis that really put things into perspective. According to them, The oncology precision medicine market, valued at USD 166 billion in 2025, is project to reach USD 185 billion in 2026 and USD 364 billion by 2035, representing a CAGR of 7.8% during the forecast period 2026 to 2035.
Market Segmentation
- Historical Trend: Since 2018
- Forecast Period: Till 2035
- Market Size 2026: USD 185 Billion
- Market Size 2035: USD 364 Billion
- CAGR (Till 2035): 7.8%
- Type of Cancer Targeted
• Bladder Cancer
• Blood / Hematologic Cancer
• Breast Cancer
• Cervical Cancer
• Gastrointestinal Cancer
• Head and Neck Squamous Cell Cancer
• Lung Cancer
• Skin Cancer
• Others
- Route of Administration
• Oral
• Intravenous
• Others
- Type of Molecule
• Small Molecules
• Biologics
- Drug Class
• Kinase Inhibitors
• Enzyme Inhibitors
• Immune Checkpoint Inhibitors
• Others
- Leading Drug Developers
• Merck
• Pfizer
• AstraZeneca
• Johnson $ Johnson Innovative Medicine
• Genentech
- Key Geographical Regions
• North America (
• Europe (
• Asia (
• Middle East and North Africa (
• Latin America (
- Key Players
• AbbVie
• Anticancer Bioscience
• Astellas Pharma
• Astrazeneca
• Bayer
• Blueprint Medicines
• Bristol Myers Squibb
• Eli Lilly
• Erasca
• Genentech
• GlaxoSmithKline
• Hutchmed
• IDEAYA Biosciences
• Jiangsu Hengrui Pharmaceuticals
• Johnson & Johnson Innovative Medicine
• Merck
• Novartis
• Pfizer
• Repare Therapeutics
• Roche
• Seagen
• SpringWorks Therapeutics
• Takeda Pharmaceutical
• VERAXA Biotech GmbH
• VRise Therapeutics
- PowerPoint Presentation (Complimentary): Available
- Customization Scope: 15% Free Customization
- Excel Data Packs (Complimentary)
• Market Landscape
• Partnerships and Collaborations
• Clinical Trial Analysis
• Case Study: Oncology Precision Medicine Assay Kits
• Market Forecast and Opportunity Analysis
Read More:
https://www.rootsanalysis.com/reports/oncology-precision-medicine-market.html
Oncology Precision Medicine Market Share, Global Industry Size, Trends, Technology, and Analysis by 2035
This report presents a detailed, data-driven analysis of the global Oncology Precision Medicine Market size, offering insights into historical performance, current dynamics, and projections from 2025 to 2035. With a strong emphasis on factual assessment, the report refrains from speculative assumptions and aims to support business decisions through accurate forecasting and strategic intelligence.
I recently came across a report by Roots Analysis that really put things into perspective. According to them, The oncology precision medicine market, valued at USD 166 billion in 2025, is project to reach USD 185 billion in 2026 and USD 364 billion by 2035, representing a CAGR of 7.8% during the forecast period 2026 to 2035.
Market Segmentation
- Historical Trend: Since 2018
- Forecast Period: Till 2035
- Market Size 2026: USD 185 Billion
- Market Size 2035: USD 364 Billion
- CAGR (Till 2035): 7.8%
- Type of Cancer Targeted
• Bladder Cancer
• Blood / Hematologic Cancer
• Breast Cancer
• Cervical Cancer
• Gastrointestinal Cancer
• Head and Neck Squamous Cell Cancer
• Lung Cancer
• Skin Cancer
• Others
- Route of Administration
• Oral
• Intravenous
• Others
- Type of Molecule
• Small Molecules
• Biologics
- Drug Class
• Kinase Inhibitors
• Enzyme Inhibitors
• Immune Checkpoint Inhibitors
• Others
- Leading Drug Developers
• Merck
• Pfizer
• AstraZeneca
• Johnson $ Johnson Innovative Medicine
• Genentech
- Key Geographical Regions
• North America (
• Europe (
• Asia (
• Middle East and North Africa (
• Latin America (
- Key Players
• AbbVie
• Anticancer Bioscience
• Astellas Pharma
• Astrazeneca
• Bayer
• Blueprint Medicines
• Bristol Myers Squibb
• Eli Lilly
• Erasca
• Genentech
• GlaxoSmithKline
• Hutchmed
• IDEAYA Biosciences
• Jiangsu Hengrui Pharmaceuticals
• Johnson & Johnson Innovative Medicine
• Merck
• Novartis
• Pfizer
• Repare Therapeutics
• Roche
• Seagen
• SpringWorks Therapeutics
• Takeda Pharmaceutical
• VERAXA Biotech GmbH
• VRise Therapeutics
- PowerPoint Presentation (Complimentary): Available
- Customization Scope: 15% Free Customization
- Excel Data Packs (Complimentary)
• Market Landscape
• Partnerships and Collaborations
• Clinical Trial Analysis
• Case Study: Oncology Precision Medicine Assay Kits
• Market Forecast and Opportunity Analysis
Read More: https://www.rootsanalysis.com/reports/oncology-precision-medicine-market.html